Related Experiment Video
Updated: May 27, 2026
07:45
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target
Jiarong Li1, Andrew C Karaplis, Dao C Huang
1Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada.
The Journal of Clinical Investigation
|November 8, 2011
Summary
Parathyroid hormone-related protein (PTHrP) drives breast cancer initiation, progression, and metastasis. Neutralizing PTHrP slowed tumor growth and spread in preclinical models, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Parathyroid hormone-related protein (PTHrP) is a secreted factor involved in development and calcium regulation.
- Dysregulated PTHrP expression in cancer can cause hypercalcemia and is linked to skeletal metastases.
- The specific role of PTHrP in breast cancer progression remains unclear.
Purpose of the Study:
- To investigate the pleiotropic involvement of PTHrP in breast cancer initiation, progression, and metastasis.
- To elucidate the molecular mechanisms by which PTHrP influences tumor development.
- To evaluate PTHrP as a potential therapeutic target for breast cancer.
Main Methods:
- Utilized the PyMT-MMTV mouse model with targeted ablation of Pthrp in mammary epithelium.
- Assessed primary tumor initiation, progression, and distant metastasis.
- Analyzed expression of key molecular markers including Ki67, factor VIII, Bcl-2, cyclin D1, AKT1, and CXCR4.
- Tested the efficacy of PTHrP-specific neutralizing antibodies in human breast cancer xenografts.
Main Results:
- Pthrp ablation delayed primary tumor initiation, inhibited progression, and reduced metastasis.
- PTHrP influenced expression of proliferation (Ki67), angiogenesis (factor VIII), anti-apoptotic (Bcl-2), cell-cycle (cyclin D1), and survival (AKT1) markers.
- Coexpression of PTHrP and CXCR4 was critical for metastatic spread.
- Neutralizing antibodies against PTHrP slowed human breast cancer xenograft progression and metastasis.
Conclusions:
- PTHrP plays multiple roles in key steps of breast cancer development and progression.
- PTHrP influences tumor cell proliferation, angiogenesis, survival, and metastasis.
- PTHrP, particularly in conjunction with CXCR4, is crucial for metastatic spread.
- PTHrP represents a promising novel therapeutic target for breast cancer treatment.
More Related Videos
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...